Rabies vaccine
This page covers all Rabies vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Rabies virus glycoprotein.
Targets
Marketed (1)
- Rabivax-S · University of Oxford · Infectious Disease / Immunology
Rabivax-S is a recombinant rabies virus vaccine that stimulates immune responses against rabies virus through viral glycoprotein antigens.